Prognostic factors for limited-stage small cell lung cancer: A study of 284 patients

Lung Cancer

Volumn 67, Issue 2, 2010, Pages 221-226

  Chen, Jun ^a,b,c   Jiang, Ruoxiang ^b   Garces, Yolanda I ^b   Jatoi, Aminah ^b   Stoddard, Shawn M ^b   Sun, Zhifu ^b   Marks, Randolph S ^b   Liu, Yunpeng ^a   Yang, Ping ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b MAYO CLINIC   (United States)

^c DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapy; Cigarette smoking; Limited stage small cell lung cancer; Performance status; Prognosis; Radiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; PLATINUM COMPLEX;

AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FUNCTIONAL STATUS; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; SEX DIFFERENCE; SMOKING HABIT; TUMOR GROWTH; TUMOR RECURRENCE; UNITED STATES;

AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; PNEUMONECTOMY; PROGNOSIS; RADIOTHERAPY; RISK FACTORS; SEX FACTORS; SMALL CELL LUNG CARCINOMA; SMOKING;

EID: 72449128994     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.04.006     Document Type: Article

References (34)

1. Lebitasy M.P., Hedelin G., Purohit A., et al. Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994. Br J Cancer 85 6 (2001) 808-815
2. Govindan R., Page N., Morgensztern D., et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 24 28 (2006) 4539-4544
3. Janne P.A., Freidlin B., Saxman S., et al. Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America. Cancer 95 7 (2002) 1528-1538
4. Laskin J.J., Erridge S.C., Coldman A.J., et al. Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia. Lung Cancer 43 1 (2004) 7-16
5. Ebbert J.O., Williams B.A., Sun Z., et al. Duration of smoking abstinence as a predictor for non-small-cell lung cancer survival in women. Lung Cancer 47 (2005) 165-172
6. Martins S.J., and Pereira J.R. Clinical factors and prognosis in non-small cell lung cancer. Am J Clin Oncol 22 (1999) 453-457
7. Videtic G.M., Stitt L.W., Dar A.R., et al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol 21 8 (2003) 1544-1549
8. Johnston-Early A., Cohen M.H., Minna J.D., et al. Smoking abstinence and small cell lung cancer survival. An association. JAMA 244 19 (1980) 2175-2179
9. Bergman B., and Sorenson S. Smoking and effect of chemotherapy in small cell lung cancer. Eur Respir J 1 (1988) 932-937
10. Perry M.C., Eaton W.L., Propert K.J., et al. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med 316 15 (1987) 912-918
11. Murray N., Coy P., Pater J.L., et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 11 2 (1993) 336-344
12. Spiro S.G., James L.E., Rudd R.M., et al. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. J Clin Oncol 24 24 (2006) 3823-3830
13. Perry M.C. Thoracic radiation therapy in limited stage small-cell lung cancer: timing is everything...isn't it?. J Clin Oncol 24 24 (2006) 3815-3816
14. Yang P., Allen M.S., Aubry M.C., et al. Clinical features of 5628 primary lung cancer patients: experience at Mayo Clinic from 1997-2003. Chest 128 1 (2005) 452-462
15. de Andrade M., Ebbert J.O., Wampfler J.A., et al. Environmental tobacco smoke exposure in women with lung cancer. Lung Cancer 43 (2004) 127-134
16. Onoda N., Nehmi A., Weiner D., et al. Nicotine affects the signaling of the death pathway, reducing the response of head and neck cancer cell lines to DNA damaging agents. Head Neck 23 10 (2001) 860-870
17. Dasgupta P., Kinkade R., Joshi B., et al. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci USA 103 16 (2006) 6332-6337
18. Heusch W.L., and Maneckjee R. Signalling pathways involved in nicotine regulation of apoptosis of human lung cancer cells. Carcinogenesis (Lond) 19 4 (1998) 551-556
19. Heeschen C., Jang J.J., Weis M., et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 7 7 (2001) 833-839
20. Mousa S., and Mousa S.A. Cellular and molecular mechanisms of nicotine's pro-angiogenesis activity and its potential impact on cancer. J Cell Biochem 97 6 (2006) 1370-1378
21. Zhang Q., Tang X., Zhang Z.F., et al. Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways. Clin Cancer Res 13 16 (2007) 4686-4694
22. Gopalakrishna R., Chen Z.H., and Gundimeda U. Tobacco smoke tumor promoters, catechol and hydroquinone, induce oxidative regulation of protein kinase C and influence invasion and metastasis of lung carcinoma cells. Proc Natl Acad Sci USA 91 25 (1994) 12233-12237
23. Browman G.P., Wong G., Hodson I., et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328 3 (1993) 159-163
24. Arriagada R., Le Chevalier T., Riviere A., et al. Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients. Ann Oncol 13 5 (2002) 748-754
25. Auperin A., Arriagada R., Pignon J.P., et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 341 7 (1999) 476-484
26. Slotman B., Faivre-Finn C., Kramer G., et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 357 7 (2007) 664-672
27. Cao K.J., Huang H.Y., Tu M.C., et al. Long-term results of prophylactic cranial irradiation for limited-stage small-cell lung cancer in complete remission. Chin Med J (Engl) 118 15 (2005) 1258-1262
28. Spiegelman D., Maurer L.H., Ware J.H., et al. Prognostic factors in small-cell carcinoma of the lung: an analysis of 1521 patients. J Clin Oncol 7 3 (1989) 344-354
29. Albain K.S., Crowley J.J., LeBlanc M., et al. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2580-patient Southwest oncology group database. J Clin Oncol 8 9 (1990) 1563-1574
30. Rawson N.S., and Peto J. An overview of prognostic factors in small cell lung cancer. A report from the subcommittee for the management of lung cancer of the United Kingdom coordinating committee on cancer research. Br J Cancer 61 4 (1990) 597-604
31. Siu L.L., Shepherd F.A., Murray N., et al. Influence of age on the treatment of limited-stage small-cell lung cancer. J Clin Oncol 14 3 (1996) 821-828
32. Ludbrook J.J., Truong P.T., MacNeil M.V., et al. Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? A community-based population analysis. Int J Radiat Oncol Biol Phys 55 5 (2003) 1321-1330
33. Schild S.E., Stella P.J., Geyer S.M., et al. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol 21 17 (2003) 3201-3206
34. Yuen A.R., Zou G., Turrisi A.T., et al. Similar outcome of elderly patients in intergroup trial 0096: cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma. Cancer 89 9 (2000) 1953-1960